NCT00001276 Diagnosing and Treating Low Blood Sugar Levels
| NCT ID | NCT00001276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Condition | Hypoglycemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 1991-05-21 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 1991-05-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed....
Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Male, females ages \>= 18. 2. Patients with documented fasting blood glucose below 55 mg/dl. 4\. Patients with biochemical evidence for insulinoma or other pancreatic neuroendocrine tumors. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Patients with significant cardiac disease will be excluded. 2. Subjects who are pregnant per self-report. 3. Medically unstable per the assessment of the PI.
Contact & Investigator
Ranganath Muniyappa, M.D.
PRINCIPAL INVESTIGATOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Frequently Asked Questions
Who can join the NCT00001276 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Hypoglycemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00001276 currently recruiting?
Yes, NCT00001276 is actively recruiting participants. Contact the research team at craigc@bdg10.niddk.nih.gov for enrollment information.
Where is the NCT00001276 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT00001276 clinical trial?
NCT00001276 is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The principal investigator is Ranganath Muniyappa, M.D. at National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The trial plans to enroll 1,500 participants.